Human Anti-SARS-CoV-2(2019-nCoV) S-NTD Antibody


Cat: MO-NAB-00897W
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

  • Product List
  • Specifications
  • Application Information
  • Target
Sub Cat Clonality Species Reactivity Application Clone Conjugate Size  
MO-NAB-00897W Monoclonal WB, ELISA NW0820 100 µg
Inquiry
MO-NAB-00908W Monoclonal WB, ELISA NW0831 100 µg
Inquiry

Specifications

Host speciesHuman (Homo sapiens)
Species ReactivitySARS-CoV-2; SARS-COV
CloneNW0820
ImmunogenRecombinant SARS-CoV-2 S-NTD protein
FormatLiquid or Lyophilized
BufferPBS, pH7.5
StorageStore at 4°C: short-term (1-2weeks)
Store at -20°C: long-term and future use

Application Information

ApplicationWB, ELISA
Application NotesWB: 1:1000-2000
Elisa: 1:5000-1:10000

Target

IntroductionCoronavirus disease 2019 is a newly emerging infectious disease that is currently spreading globally. It is caused by a new type of coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The spike (S) protein of SARS-CoV-2 plays a key role in the process of receptor recognition and cell membrane fusion, and is composed of two subunits S1 and S2. The S1 subunit contains a receptor binding domain that recognizes and binds to the host receptor angiotensin converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helix bundle through two heptapeptide repeat domains. In this review, we focused on the latest research progress in the structure, function and development of antiviral drugs targeting S protein.
Product OverviewRecombinant anti-SARS-CoV-2 S-NTD antibody is expressed from XtenCHO
Alternative Names2019-nCoV S-NTD; N-terminal domain of the Spike protein of 2019-nCoV
For Research Use Only | Not For Clinical Use.
Online Inquiry